IHH Healthcare Berhad
Market Cap
RM49.5b
Last Updated
2021/08/01 11:04 UTC
Data Sources
Company Financials +
Executive Summary
IHH Healthcare Berhad, an investment holding company, provides healthcare services in Malaysia, Singapore, Turkey, India, and internationally. More Details
Rewards
Risk Analysis
Snowflake Analysis
Adequate balance sheet with acceptable track record.
Similar Companies
Share Price & News
How has IHH Healthcare Berhad's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: IHH is less volatile than 75% of MY stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: IHH's weekly volatility (4%) has been stable over the past year.
Market Performance
7 Day Return
-2.9%
IHH
-2.4%
MY Healthcare
-1.9%
MY Market
1 Year Return
4.4%
IHH
7.1%
MY Healthcare
-1.5%
MY Market
Return vs Industry: IHH underperformed the MY Healthcare industry which returned 7.1% over the past year.
Return vs Market: IHH exceeded the MY Market which returned -1.5% over the past year.
Shareholder returns
| IHH | Industry | Market | |
|---|---|---|---|
| 7 Day | -2.9% | -2.4% | -1.9% |
| 30 Day | 0.5% | 1.0% | -1.3% |
| 90 Day | 7.2% | 4.4% | -6.6% |
| 1 Year | 5.2%4.4% | 7.9%7.1% | 2.1%-1.5% |
| 3 Year | -2.4%-4.4% | -0.9%-3.2% | -3.6%-12.7% |
| 5 Year | -11.0%-13.6% | -9.8%-13.1% | 8.7%-9.6% |
Long-Term Price Volatility Vs. Market
How volatile is IHH Healthcare Berhad's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall St
A Look At IHH Healthcare Berhad's (KLSE:IHH) Share Price Returns1 month ago | Simply Wall St
Return Trends At IHH Healthcare Berhad (KLSE:IHH) Aren't Appealing2 months ago | Simply Wall St
Estimating The Fair Value Of IHH Healthcare Berhad (KLSE:IHH)Valuation
Is IHH Healthcare Berhad undervalued compared to its fair value and its price relative to the market?
12.8%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: IHH (MYR5.64) is trading below our estimate of fair value (MYR6.47)
Significantly Below Fair Value: IHH is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: IHH's PE Ratio (55.3x) is in line with the MY Healthcare industry average.
PE vs Market: IHH is poor value based on its PE Ratio (55.3x) compared to the MY market (17.3x).
Price to Earnings Growth Ratio
PEG Ratio: IHH is poor value based on its PEG Ratio (2.9x)
Price to Book Ratio
PB vs Industry: IHH is good value based on its PB Ratio (2.1x) compared to the MY Healthcare industry average (3x).
Future Growth
How is IHH Healthcare Berhad forecast to perform in the next 1 to 3 years based on estimates from 18 analysts?
19.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IHH's forecast earnings growth (19.2% per year) is above the savings rate (3.6%).
Earnings vs Market: IHH's earnings (19.2% per year) are forecast to grow faster than the MY market (10.9% per year).
High Growth Earnings: IHH's earnings are forecast to grow, but not significantly.
Revenue vs Market: IHH's revenue (9% per year) is forecast to grow faster than the MY market (6.1% per year).
High Growth Revenue: IHH's revenue (9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IHH's Return on Equity is forecast to be low in 3 years time (5.6%).
Past Performance
How has IHH Healthcare Berhad performed over the past 5 years?
-26.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IHH has a large one-off gain of MYR414.4M impacting its March 31 2021 financial results.
Growing Profit Margin: IHH's current net profit margins (6.5%) are higher than last year (0.4%).
Past Earnings Growth Analysis
Earnings Trend: IHH's earnings have declined by 26.9% per year over the past 5 years.
Accelerating Growth: IHH's earnings growth over the past year (1582.7%) exceeds its 5-year average (-26.9% per year).
Earnings vs Industry: IHH earnings growth over the past year (1582.7%) exceeded the Healthcare industry -7.8%.
Return on Equity
High ROE: IHH's Return on Equity (3.7%) is considered low.
Financial Health
How is IHH Healthcare Berhad's financial position?
Financial Position Analysis
Short Term Liabilities: IHH's short term assets (MYR7.8B) exceed its short term liabilities (MYR5.5B).
Long Term Liabilities: IHH's short term assets (MYR7.8B) do not cover its long term liabilities (MYR12.5B).
Debt to Equity History and Analysis
Debt Level: IHH's debt to equity ratio (35.9%) is considered satisfactory.
Reducing Debt: IHH's debt to equity ratio has increased from 27.2% to 35.9% over the past 5 years.
Debt Coverage: IHH's debt is well covered by operating cash flow (26.3%).
Interest Coverage: IHH's interest payments on its debt are well covered by EBIT (4.3x coverage).
Balance Sheet
Dividend
What is IHH Healthcare Berhad current dividend yield, its reliability and sustainability?
0.71%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: IHH's dividend (0.71%) isn’t notable compared to the bottom 25% of dividend payers in the MY market (1.51%).
High Dividend: IHH's dividend (0.71%) is low compared to the top 25% of dividend payers in the MY market (4.17%).
Stability and Growth of Payments
Stable Dividend: IHH is not paying a notable dividend for the MY market, therefore no need to check if payments are stable.
Growing Dividend: IHH is not paying a notable dividend for the MY market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: IHH is not paying a notable dividend for the MY market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of IHH's dividend in 3 years as they are not forecast to pay a notable one for the MY market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.5yrs
Average management tenure
CEO
Kelvin Loh (47 yo)
1.5yrs
Tenure
RM20,234,000
Compensation
Dr. Chi-Keon Loh, also known as Kelvin, serves as Managing Director and Chief Executive Officer of IHH Healthcare Berhad since January 1, 2020 and serves as its Executive Director since July 01, 2019. He h...
CEO Compensation Analysis
Compensation vs Market: Kelvin's total compensation ($USD4.79M) is above average for companies of similar size in the MY market ($USD1.88M).
Compensation vs Earnings: Kelvin's compensation has increased by more than 20% in the past year.
Leadership Team
Experienced Management: IHH's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
Experienced Board: IHH's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
IHH Healthcare Berhad's company bio, employee growth, exchange listings and data sources
Key Information
- Name: IHH Healthcare Berhad
- Ticker: IHH
- Exchange: KLSE
- Founded: 1974
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: RM49.514b
- Shares outstanding: 8.78b
- Website: https://www.ihhhealthcare.com
Number of Employees
Location
- IHH Healthcare Berhad
- Pantai Hospital Kuala Lumpur
- Level 11, Block A
- Kuala Lumpur
- Wilayah Persekutuan
- 59100
- Malaysia
Listings
Biography
IHH Healthcare Berhad, an investment holding company, provides healthcare services in Malaysia, Singapore, Turkey, India, and internationally. It provides primary care services, such as treatment of basic ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/08/01 11:04 |
| End of Day Share Price | 2021/07/30 00:00 |
| Earnings | 2021/03/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.